Nobel Biocare Plans To Fill Marketing Gap Via $97 Mil. Steri-Oss Acquisition
This article was originally published in The Gray Sheet
Executive SummaryNobel Biocare anticipates leveraging the financial resources of Steri-Oss to enhance consumer awareness of dental implants through direct-to-consumer marketing.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.